A Comprehensive Narrative Review of Diagnostic Biomarkers in Human Primary Membranous Nephropathy

References

• Rychlík I , JančováE, TesařVet al. The Czech registry of renal biopsies. Occurrence of renal diseases in the years 1994–2000. Nephrol. Dial. Transplant.19(12), 3040–3049 (2004).
   PubMed Web of Science ®Google Scholar
• Hogan SL , MullerKE, JennetteJC, FalkRJ. A review of therapeutic studies of idiopathic membranous glomerulopathy. Am. J. Kidney Dis.25(6), 862–875 (1995).
   PubMed Web of Science ®Google Scholar
• Beck LH , SalantDJ. Membranous nephropathy: from models to man. J. Crit. Invest.124(6), 2307–2314 (2014).
   PubMed Web of Science ®Google Scholar
• Mcquarrie EP , MackinnonB, StewartGA, GeddesCC. Membranous nephropathy remains the commonest primary cause of nephrotic syndrome in a northern European Caucasian population. Nephrol. Dial. Transplant.25(3), 1009–1010 (2010).
   PubMed Web of Science ®Google Scholar
• Cambier J-F , RoncoP. Onco-nephrology: glomerular diseases with cancer. Clin. J. Am. Soc. Nephrol.7(10), 1701–1712 (2012).
   PubMed Web of Science ®Google Scholar
• Bacchetta J , JuillardL, CochatP, DrozJ-P. Paraneoplastic glomerular diseases and malignancies. Crit. Rev. Onc./Hem.70(1), 39–58 (2009).
   PubMed Web of Science ®Google Scholar
• Beck LH . Membranous nephropathy and malignancy. Semin. Nephrol.30(6), 635–644 (2010).
   PubMed Web of Science ®Google Scholar
• Kwatra IS , PrasherP. Pathogenesis of membranous nephropathy: update. J. Assoc. Phys. India61, 807–810 (2013).
   PubMedGoogle Scholar
• Chadban S , AtkinsR. Glomerulonephritis. Lancet365(9473), 1797–1806 (2005).
   PubMed Web of Science ®Google Scholar
• Glassock RJ . Diagnosis and natural course of membranous nephropathy. Semin. Nephrol.23(4), 324–332 (2003).
   PubMed Web of Science ®Google Scholar
• Appel G . Renal biopsy. How effective, what technique and how safe?J. Nephrol.6, 4 (1993).
   Google Scholar
• Parrish A . Complications of percutaneous renal biopsy: a review of 37 years’ experience. Clin. Nephrol.38(3), 135–141 (1992).
   PubMed Web of Science ®Google Scholar
• Lai WL , YehTH, ChenPMet al. Membranous nephropathy: a review on the pathogenesis, diagnosis, and treatment. J. Form. Med. Assoc.114(2), 102–111 (2015).
   PubMed Web of Science ®Google Scholar
• Lee BH , ChoHY, KangHGet al. Idiopathic membranous nephropathy in children. Ped. Nephrol.21(11), 1707–1715 (2006).
   PubMed Web of Science ®Google Scholar
• Bazzi C , RizzaV, CasellatoDet al. Fractional excretion of IgG in idiopathic membranous nephropathy with nephrotic syndrome: a predictive marker of risk and drug responsiveness. BMC Nephrol.15(1), 74 (2014).
   PubMedGoogle Scholar
• Rodriguez E , CosioFG, NasrSHet al. The pathology and clinical features of early recurrent membranous glomerulonephritis. Am. J. Transplant.12(4), 1029–1038 (2012).
   PubMed Web of Science ®Google Scholar
• Ayalon R , BeckLH. Membranous nephropathy: not just a disease for adults. Ped. Nephrol.30(1), 31–39 (2015).
   PubMed Web of Science ®Google Scholar
• Segawa Y , HisanoS, MatsushitaMet al. IgG subclasses and complement pathway in segmental and global membranous nephropathy. Ped. Nephrol.25(6), 1091–1099 (2010).
   PubMed Web of Science ®Google Scholar
• Mellors RC , OrtegaLG, HolmanHR. Role of gamma globulins in pathogenesis of renal lesions in systemic lupus erythematosus and chronic membranous glomerulonephritis, with an observation on the lupus erythematosus cell reaction. J. Exp. Med.106(2), 191–202 (1957).
   PubMed Web of Science ®Google Scholar
• Huang CC , LehmanA, AlbawardiAet al. IgG subclass staining in renal biopsies with membranous glomerulonephritis indicates subclass switch during disease progression. Mod. Pathol.26(6), 799–805 (2013).
   PubMed Web of Science ®Google Scholar
• Wasserstein AG . Membranous glomerulonephritis. J. Am. Soc. Nephrol.8(4), 664–674 (1997).
   PubMed Web of Science ®Google Scholar
• Ronco P , DebiecH. Pathophysiological advances in membranous nephropathy: time for a shift in patient's care. Lancet385(9981), 1983–1992 (2015).
   PubMed Web of Science ®Google Scholar
• Walport MJ . Complement. First of two parts. N. Engl. J. Med.344(14), 1058–1066 (2001).
   PubMed Web of Science ®Google Scholar
• Topham PS , HaydarSA, KuphalR, LightfootJD, SalantDJ. Complement-mediated injury reversibly disrupts glomerular epithelial cell actin microfilaments and focal adhesions. Kidney Int.55(5), 1763–1775 (1999).
   PubMed Web of Science ®Google Scholar
• Petermann AT , KrofftR, BlonskiMet al. Podocytes that detach in experimental membranous nephropathy are viable. Kidney Int.64(4), 1222–1231 (2003).
   PubMed Web of Science ®Google Scholar
• Endo M , FukeY, TamanoMet al. Glomerular deposition and urinary excretion of complement factor H in idiopathic membranous nephropathy. Nephron. Clin. Pract.97(4), c147–c153 (2004).
   PubMedGoogle Scholar
• Schulze M , DonadioJV, PruchnoCJet al. Elevated urinary excretion of the C5b-9 complex in membranous nephropathy. Kidney Int.40(3), 533–538 (1991).
   PubMed Web of Science ®Google Scholar
• Ma H , SandorDG, BeckLH. The role of complement in membranous nephropathy. Semin. Nephrol.33(6), 531–542 (2013).
   PubMed Web of Science ®Google Scholar
• Salant DJ . Genetic variants in membranous nephropathy: perhaps a perfect storm rather than a straightforward conformeropathy?J. Am. Soc. Nephrol.24(4), 525–528 (2013).
   PubMed Web of Science ®Google Scholar
• Beck LH Jr , BonegioRG, LambeauGet al. M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N. Engl. J. Med.361(1), 11–21 (2009).
   PubMed Web of Science ®Google Scholar
• Hofstra JM , BeckLH, BeckDM, WetzelsJF, SalantDJ. Anti-phospholipase A2 receptor antibodies correlate with clinical status in idiopathic membranous nephropathy. Clin. J. Am. Soc. Nephrol.6(6), 1286–1291 (2011).
   PubMed Web of Science ®Google Scholar
• Qin W , BeckLH, ZengCet al. Anti-phospholipase A2 receptor antibody in membranous nephropathy. J. Am. Soc. Nephrol.22(6), 1137–1143 (2011).
   PubMed Web of Science ®Google Scholar
• Debiec H , HanoyM, FrancoisAet al. Recurrent membranous nephropathy in an allograft caused by IgG3κ targeting the PLA2 receptor. J. Am. Soc. Nephrol.23(12), 1949–1954 (2012).
   PubMed Web of Science ®Google Scholar
• Du Y , LiJ, HeFet al. The diagnosis accuracy of PLA2R-AB in the diagnosis of idiopathic membranous nephropathy: a meta-analysis. PLoS ONE9(8), e104936 (2014).
   PubMed Web of Science ®Google Scholar
• Dai H , ZhangH, HeY. Diagnostic accuracy of PLA2R autoantibodies and glomerular staining for the differentiation of idiopathic and secondary membranous nephropathy: an updated meta-analysis. Sci. Rep.5, 8803 (2015).
   PubMed Web of Science ®Google Scholar
• Tomas NM , BeckLHJr, Meyer-SchwesingerCet al. Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy. N. Engl. J. Med.371(24), 2277–2287 (2014).
   PubMed Web of Science ®Google Scholar
• Tomas NM , HoxhaE, ReinickeATet al. Autoantibodies against thrombospondin type 1 domain-containing 7A induce membranous nephropathy. J. Clin. Invest.126(7), 2519 (2016).
   PubMed Web of Science ®Google Scholar
• Hoxha E , BeckLH, WiechTet al. An indirect immunofluorescence method facilitates detection of thrombospondin type 1 domain-containing 7A-specific antibodies in membranous nephropathy. J. Am. Soc. Nephrol.28(2), 520–531 (2016).
   PubMed Web of Science ®Google Scholar
• Debiec H , GuigonisV, MougenotBet al. Antenatal membranous glomerulonephritis due to anti-neutral endopeptidase antibodies. N. Engl. J. Med.346(26), 2053–2060 (2002).
   PubMed Web of Science ®Google Scholar
• Debiec H , NautaJ, CouletFet al. Role of truncating mutations in MME gene in fetomaternal alloimmunisation and antenatal glomerulopathies. Lancet364(9441), 1252–1259 (2004).
   PubMed Web of Science ®Google Scholar
• Yue H , TurnerAJ. Old enzyme with new interest: review of newly understood NEP functions and its potential regulators. Zhongguo Shengwu Huaxue yu Fenzi Shengwu Xuebao23(2), 85–92 (2007).
   Google Scholar
• Woodard GE , RosadoJA. Recent advances in natriuretic peptide research. J. Cell. Mol. Med.11(6), 1263–1271 (2007).
   PubMed Web of Science ®Google Scholar
• Hu P , XuanQ, HuB, LuL, QinYH. Anti-neutral endopeptidase, natriuretic peptides disarrangement, and proteinuria onset in membranous nephropathy. Mol. Biol. Rep.40(4), 2963–2967 (2013).
   PubMed Web of Science ®Google Scholar
• Lin L , WangWM, PanXXet al. Biomarkers to detect membranous nephropathy in Chinese patients. Oncotarget7(42), 67868–67879 (2016).
   PubMedGoogle Scholar
• Kozioł M , SikoraA, Kozioł-MontewkaMet al. Preliminary results of research on a new marker of idiopathic membranous nephropathy: anti-PLA2R. Pol. Merkur. Lekarski.36(213), 171–174 (2014).
   PubMedGoogle Scholar
• Svobodova B , HonsovaE, RoncoP, TesarV, DebiecH. Kidney biopsy is a sensitive tool for retrospective diagnosis of PLA2R-related membranous nephropathy. Nephrol. Dial. Transplant.28(7), 1839–1844 (2012).
   PubMed Web of Science ®Google Scholar
• Oh YJ , YangSH, KimDK, KangS-W, KimYS. Autoantibodies against phospholipase A 2 receptor in Korean patients with membranous nephropathy. PLoS ONE8(4), e62151 (2013).
   PubMed Web of Science ®Google Scholar
• Ardalan M-R , NasriH. Anti-phospholipase A2 receptor antibody in idiopathic membranous nephropathy: new concepts. J. Res. Med. Sci.18(6), 459 (2013).
   PubMed Web of Science ®Google Scholar
• Larsen CP , CosseyLN, BeckLH. THSD7A staining of membranous glomerulopathy in clinical practice reveals cases with dual autoantibody positivity. Mod. Pathol.29(4), 421–426 (2016).
   PubMed Web of Science ®Google Scholar
• Iwakura T , OhashiN, KatoA, BabaS, YasudaH. Prevalence of enhanced granular expression of thrombospondin type-1 domain-containing 7A in the glomeruli of Japanese patients with idiopathic membranous nephropathy. PLoS ONE10(9), e0138841 (2015).
   PubMed Web of Science ®Google Scholar
• Hill PA , McraeJL, DwyerKM. PLA2R and membranous nephropathy: a 3 year prospective Australian study. Nephrology21(5), 397–403 (2016).
   PubMed Web of Science ®Google Scholar
• Kumar V , RamachandranR, KumarAet al. Antibodies to m-type phospholipase A2 receptor in children with idiopathic membranous nephropathy. Nephrology20(8), 572–575 (2015).
   PubMed Web of Science ®Google Scholar
• Lin W , LiH, LiXet al. The relationship between anti-phospholipase A2 receptor antibody and idiopathic membranous nephropathy. Zhonghua nei ke za zhi54(9), 783–788 (2015).
   PubMedGoogle Scholar
• Vivarelli M , EmmaF, PelléTet al. Genetic homogeneity but IgG subclass–dependent clinical variability of alloimmune membranous nephropathy with anti-neutral endopeptidase antibodies. Kidney Int.87(3), 602–609 (2015).
   PubMed Web of Science ®Google Scholar
• Verma M , DuttaS. DNA sequences encoding enolase are remarkably conserved from yeast to mammals. Life Sci.55(12), 893–899 (1994).
   PubMed Web of Science ®Google Scholar
• Walter M , BergH, LeidenbergerFA, SchweppeK-W, NorthemannW. Autoreactive epitopes within the human α-enolase and their recognition by sera from patients with endometriosis. J. Autoimmun.8(6), 931–945 (1995).
   PubMed Web of Science ®Google Scholar
• Adamus G , AptsiauriN, GuyJ, HeckenlivelyJ, FlanneryJ, HargravePA. The occurrence of serum autoantibodies against enolase in cancer-associated retinopathy. Clin. Immunol. Immunopathol.78(2), 120–129 (1996).
   PubMedGoogle Scholar
• Sabbatini A , DolcherM, MarchiniBet al. Alpha-enolase is a renal-specific antigen associated with kidney involvement in mixed cryoglobulinemia. Clin. Exp. Rheumatol.15(6), 655–658 (1996).
   Web of Science ®Google Scholar
• Gitlits V , SentryJ, MatthewM, SmithA, TohBH. Autoantibodies to evolutionarily conserved epitopes of enolase in a patient with discoid lupus erythematosus. Immunology92(3), 362–368 (1997).
   PubMed Web of Science ®Google Scholar
• Wakui H , ImaiH, KomatsudaA, MiuraA. Circulating antibodies against α-enolase in patients with primary membranous nephropathy (MN). Clin. Exp. Immunol.118(3), 445 (1999).
   PubMed Web of Science ®Google Scholar
• Murtas C , BruschiM, CandianoGet al. Coexistence of different circulating anti-podocyte antibodies in membranous nephropathy. Clin. J. Am. Soc. Nephrol.7(9), 1394–1400 (2012).
   PubMed Web of Science ®Google Scholar
• Bruschi M , CarnevaliML, MurtasCet al. Direct characterization of target podocyte antigens and auto-antibodies in human membranous glomerulonephritis: Alfa-enolase and borderline antigens. J. Proteome74(10), 2008–2017 (2011).
   PubMed Web of Science ®Google Scholar
• Prunotto M , CarnevaliML, CandianoGet al. Autoimmunity in membranous nephropathy targets aldose reductase and SOD2. J. Am. Soc. Nephrol.21(3), 507–519 (2010).
   PubMed Web of Science ®Google Scholar
• Srivastava S , SpiteM, TrentJO, WestMB, AhmedY, BhatnagarA. Aldose reductase-catalyzed reduction of aldehyde phospholipids. J. Biol. Chem.279(51), 53395–53406 (2004).
   PubMed Web of Science ®Google Scholar
• Heymann W , LundH, HackelD. The nephrotic syndrome in rats; with special reference to the progression of the glomerular lesion and to the use of nephrotoxic sera obtained from ducks. J. Lab. Clin. Med.39(2), 218–224 (1952).
   PubMed Web of Science ®Google Scholar
• Konvalinka A , ScholeyJW, DiamandisEP. Searching for new biomarkers of renal diseases through proteomics. Clin. Chem.58(2), 353–365 (2012).
   PubMed Web of Science ®Google Scholar
• Wilkins MR , SanchezJ-C, GooleyAAet al. Progress with proteome projects: why all proteins expressed by a genome should be identified and how to do it. Biotech. Gene Eng. Rev.13(1), 19–50 (1996).
   PubMed Web of Science ®Google Scholar
• Cagney G , ParkS, ChungCet al. Human tissue profiling with multidimensional protein identification technology. J. Proteome Res.4(5), 1757–1767 (2005).
   PubMed Web of Science ®Google Scholar
• Kalantari S , RutishauserD, SamavatSet al. Urinary prognostic biomarkers and classification of IgA nephropathy by high resolution mass spectrometry coupled with liquid chromatography. PLoS ONE8(12), e80830 (2013).
   PubMed Web of Science ®Google Scholar
• Samavat S , KalantariS, NafarMet al. Diagnostic urinary proteome profile for immunoglobulin a nephropathy. Iran. J. Kid. Dis.9(3), 239–248 (2015).
   PubMed Web of Science ®Google Scholar
• Nafar M , KalantariS, SamavatS, Rezaei-TaviraniM, RutishuserD, ZubarevRA. The novel diagnostic biomarkers for focal segmental glomerulosclerosis. Int. J. Nephrol. 2014, 574261 (2014).
   PubMedGoogle Scholar
• Kalantari S , NafarM, SamavatS, Rezaei-TaviraniM, RutishauserD, ZubarevR. Urinary prognostic biomarkers in patients with focal segmental glomerulosclerosis. Nephrourol. Mon.6(2), e16806 (2014).
   PubMedGoogle Scholar
• Kalantari S , NafarM, RutishauserDet al. Predictive urinary biomarkers for steroid-resistant and steroid-sensitive focal segmental glomerulosclerosis using high resolution mass spectrometry and multivariate statistical analysis. BMC Nephrol.15(1), 141 (2014).
   PubMedGoogle Scholar
• Kalantari S , NafarM, Rezaei-TaviraniM. Urinary proteomics in nephrotic syndrome. J. ParaMed. Sci.4(4), 108–115 (2013).
   Google Scholar
• Kalantari S , JafariA, MoradpoorR, GhasemiE, KhalkhalE. Human urine proteomics: analytical techniques and clinical applications in renal diseases. Int. J. Proteom.2015, 782798 (2015).
   PubMedGoogle Scholar
• Rood IM , MerchantML, WilkeyDWet al. Increased expression of lysosome membrane protein 2 in glomeruli of patients with idiopathic membranous nephropathy. Proteomics15(21), 3722–3730 (2015).
   PubMed Web of Science ®Google Scholar
• Beeken M , LindenmeyerMT, BlattnerSMet al. Alterations in the ubiquitin proteasome system in persistent but not reversible proteinuric diseases. J. Am. Soc. Nephrol.25(11), 2511–2525 (2014).
   PubMed Web of Science ®Google Scholar
• Lee DHK , GanP-Y, KaterelosMet al. Absence of the lysosomal protein Limp-2 attenuates renal injury in crescentic glomerulonephritis. Immunol. Cell Biol.92(5), 400–408 (2014).
   PubMed Web of Science ®Google Scholar
• Giulia L , RiccardoM, MarcoCet al. Identification and characterization of new proteins in podocyte dysfunction of membranous nephropathy by proteomic analysis of renal biopsy. Curr. Pharmacogen. Pers. Med.11(1), 42–52 (2013).
   Google Scholar
• Sui W , ZhangR, ChenJet al. Comparative proteomic analysis of membranous nephropathy biopsy tissues using quantitative proteomics. Exp. Ther. Med.9(3), 805–810 (2015).
   PubMed Web of Science ®Google Scholar
• Ferguson MA , WaikarSS. Established and emerging markers of kidney function. Clin. Chem.58(4), 680–689 (2012).
   PubMed Web of Science ®Google Scholar
• Van Den Brand JA , HofstraJM, WetzelsJF. Prognostic value of risk score and urinary markers in idiopathic membranous nephropathy. Clin. J. Am. Soc. Nephrol.7(8), 1242–1248 (2012).
   PubMed Web of Science ®Google Scholar
• Van Den Brand JA , HofstraJM, WetzelsJF. Low-molecular-weight proteins as prognostic markers in idiopathic membranous nephropathy. Clin. J. Am. Soc. Nephrol.6(12), 2846–2853 (2011).
   PubMed Web of Science ®Google Scholar
• Kerjaschki D , SharkeyDJ, FarquharMG. Identification and characterization of podocalyxin – the major sialoprotein of the renal glomerular epithelial cell. J. Cell Biol.98(4), 1591–1596 (1984).
   PubMed Web of Science ®Google Scholar
• Hara M , YamamotoT, YanagiharaTet al. Urinary excretion of podocalyxin indicates glomerular epithelial cell injuries in glomerulonephritis. Nephron69(4), 397–403 (1995).
   PubMed Web of Science ®Google Scholar
• Imaizumi T , NakatochiM, AkiyamaSIet al. Urinary podocalyxin as a biomarker to diagnose membranous nephropathy. PLoS ONE11(9), e0163507 (2016).
   PubMed Web of Science ®Google Scholar
• Sui W , DaiY, ZhangY, ChenJ, LiuH, HuangH. Proteomic profiling of nephrotic syndrome in serum using magnetic bead based sample fractionation & MALDI-TOF MS. Indian J. Med. Res.135(3), 305 (2012).
   PubMed Web of Science ®Google Scholar
• Huang L , WenQ, ZhaoMet al. Serum peptidome profiling for identifying pathological patterns in patients with primary nephrotic syndrome. Chinese J. Med. Res.125(24), 4418–4423 (2012).
   PubMed Web of Science ®Google Scholar
• Cheng C-W , ChangL-C, TsengT-L, WuC-C, LinY-F, ChenJ-S. Phosphotriesterase-related protein sensed albuminuria and conferred renal tubular cell activation in membranous nephropathy. J. BioMed. Sci.21(1), 573 (2014).
   Google Scholar
• Seki T , AsanumaK, AsaoRet al. Significance of urinary full-length megalin in patients with IgA nephropathy. PLoS ONE9(12), e114400 (2014).
   PubMed Web of Science ®Google Scholar
• Wang Q , PangW, CuiZet al. Upregulation of soluble epoxide hydrolase in proximal tubular cells mediated proteinuria-induced renal damage. Am. J. Physiol. Renal. Physiol.304(2), F168–F176 (2013).
   PubMed Web of Science ®Google Scholar
• Sha W-G , ShenL, ZhouL, XuD-Y, LuG-Y. Down-regulation of miR-186 contributes to podocytes apoptosis in membranous nephropathy. BioMed. Pharmacother.75, 179–184 (2015).
   PubMed Web of Science ®Google Scholar
• Jiang S , ChuangPY, LiuZ-H, HeJC. The primary glomerulonephritides: a systems biology approach. Nat. Rev. Nephrol.9(9), 500–512 (2013).
   PubMed Web of Science ®Google Scholar
• Hodgin JB , CohenCD. Experimental approaches to the human renal transcriptome. Semin. Nephrol.30(5), 455–467 (2010).
   PubMed Web of Science ®Google Scholar
• Pesce F , PathanS, SchenaFP. From omics to personalized medicine in nephrology: integration is the key. Nephrol. Dial. Transplant.28(1), 24–28 (2013).
   PubMed Web of Science ®Google Scholar
• Sui W , HeH, YanQ, ChenJ, ZhangR, DaiY. ChIP-seq analysis of histone H3K9 trimethylation in peripheral blood mononuclear cells of membranous nephropathy patients. Braz. J. Med. Biol. Res.47(1), 42–49 (2014).
   PubMed Web of Science ®Google Scholar
• Cai X , LiuN, QiaoYet al. Decreased TIM-3 mRNA expression in peripheral blood mononuclear cells from nephropathy patients. Genet. Mol. Res.14(2), 6543–6548 (2015).
   PubMed Web of Science ®Google Scholar
• Lee J , PhongB, EgloffAM, KaneLP. TIM polymorphisms – genetics and function. Gene Immun.12(8), 595–604 (2011).
   PubMed Web of Science ®Google Scholar
• Nagasawa Y , OkuzakiD, MusoEet al. IFI27 Is a useful genetic marker for diagnosis of immunoglobulin A nephropathy and membranous nephropathy using peripheral blood. PLoS ONE11(4), e0153252 (2016).
   PubMed Web of Science ®Google Scholar
• Liu S , MeiP, ShiWet al. Urinary messenger RNA of the receptor activator of NF-kappaB could be used to differentiate between minimal change disease and membranous nephropathy. Biomarkers19(7), 597–603 (2014).
   PubMed Web of Science ®Google Scholar
• Liu S , ShiW, XiaoHet al. Receptor activator of NF-kappaB and podocytes: towards a function of a novel receptor-ligand pair in the survival response of podocyte injury. PLoS ONE7(7), e41331 (2012).
   PubMed Web of Science ®Google Scholar
• Mezzano SA , DroguettMA, BurgosMEet al. Overexpression of chemokines, fibrogenic cytokines, and myofibroblasts in human membranous nephropathy. Kidney Int.57(1), 147–158 (2000).
   PubMed Web of Science ®Google Scholar
• Kuroki A , IyodaM, ShibataT, SugisakiT. Th2 cytokines increase and stimulate B cells to produce IgG4 in idiopathic membranous nephropathy. Kidney Int.68(1), 302–310 (2005).
   PubMed Web of Science ®Google Scholar
• Reyes-Thomas J , BlancoI, PuttermanC. Urinary biomarkers in lupus nephritis. Clin. Rev. Aller. Immunol.40(3), 138–150 (2011).
   PubMed Web of Science ®Google Scholar
• Sanchez-Niño MD , PovedaJ, SanzABet al. Fn14 in podocytes and proteinuric kidney disease. Biochim. Biophys. Acta1832(12), 2232–2243 (2013).
   PubMed Web of Science ®Google Scholar
• Yoshimoto K , WadaT, FuruichiK, SakaiN, IwataY, YokoyamaH. CD68 and MCP-1/CCR2 expression of initial biopsies reflect the outcomes of membranous nephropathy. Nephron. Clin. Pract.98(1), c25–c34 (2004).
   PubMedGoogle Scholar
• Esteller M . Non-coding RNAs in human disease. Nat. Rev. Genet.12(12), 861–874 (2011).
   PubMed Web of Science ®Google Scholar
• Bartel DP . MicroRNAs: genomics, biogenesis, mechanism, and function. Cell116(2), 281–297 (2004).
   PubMed Web of Science ®Google Scholar
• Wang G , TamL, LiEet al. Serum and urinary free microRNA level in patients with systemic lupus erythematosus. Lupus20(5), 493–500 (2011).
   PubMed Web of Science ®Google Scholar
• Neal CS , MichaelMZ, PimlottLK, YongTY, LiJY, GleadleJM. Circulating microRNA expression is reduced in chronic kidney disease. Nephrol. Dial. Transplant.26(11), 3794–3802 (2011).
   PubMed Web of Science ®Google Scholar
• Lorenzen JM , KielsteinJT, HaferCet al. Circulating miR-210 predicts survival in critically ill patients with acute kidney injury. Clin. J. Am. Soc. Nephrol.6(7), 1540–1546 (2011).
   PubMed Web of Science ®Google Scholar
• Chen W , LinX, HuangJet al. Integrated profiling of microRNA expression in membranous nephropathy using high-throughput sequencing technology. Int. J. Mol. Med.33(1), 25–34 (2014).
   PubMed Web of Science ®Google Scholar
• Ifuku M , MiyakeK, WatanebeMet al. Various roles of Th cytokine mRNA expression in different forms of glomerulonephritis. Am. J. Nephrol.38(2), 115–123 (2013).
   PubMed Web of Science ®Google Scholar
• Wickman L , AfshinniaF, WangSQet al. Urine podocyte mRNAs, proteinuria, and progression in human glomerular diseases. J. Am. Soc. Nephrol.24(12), 2081–2095 (2013).
   PubMed Web of Science ®Google Scholar
• Lavoz C , DroguettA, BurgosMEet al. Translational study of the Notch pathway in hypertensive nephropathy. Nefrologia34(3), 369–376 (2014).
   PubMed Web of Science ®Google Scholar
• Wang G , KwanBC-H, LaiFM-M, ChowK-M, LiPK-T, SzetoC-C. Urinary sediment miRNA levels in adult nephrotic syndrome. Clin. Chim. Acta418, 5–11 (2013).
   PubMed Web of Science ®Google Scholar
• Zhang W , ZhangC, ChenHet al. Evaluation of microRNAs miR-196a, miR-30a-5P, and miR-490 as biomarkers of disease activity among patients with FSGS. Clin. J. Am. Soc. Nephrol.9(9), 1545–1552 (2014).
   PubMed Web of Science ®Google Scholar
• Shi X , QuZ, ZhangLet al. Increased ratio of ICOS+/PD-1+ follicular helper T cells positively correlates with the development of human idiopathic membranous nephropathy. Clin. Exp. Pharmacol. Physiol.43(4), 410–416 (2016).
   PubMed Web of Science ®Google Scholar
• Wang B , ZuoK, WuYet al. Correlation between B lymphocyte abnormality and disease activity in patients with idiopathic membranous nephropathy. J. Int. Med. Res.39(1), 86–95 (2011).
   PubMed Web of Science ®Google Scholar
• Pozdzik A , BeukingaI, Gu-TrantienC, Willard-GalloK, NortierJ, PradierO. Circulating (CD3-CD19+CD20-IgD-CD27highCD38high) plasmablasts: a promising cellular biomarker for immune activity for anti-PLA2R1 related membranous nephropathy. Mediators Inflamm.2016, 7651024 (2016).
   PubMed Web of Science ®Google Scholar
• Zhu B , HuangJ. Successful treatment and clearing of circulating CD19-positive cells by rituximab in a child with idiopathic membranous nephropathy. Ped. Nephrol.26(4), 637–638 (2011).
   PubMed Web of Science ®Google Scholar
• Nicholson JK , LindonJC, HolmesE. ‘Metabonomics’: understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica29(11), 1181–1189 (1999).
   PubMed Web of Science ®Google Scholar
• Zhao Y-Y . Metabolomics in chronic kidney disease. Clin. Chim. Acta422, 59–69 (2013).
   PubMed Web of Science ®Google Scholar
• Darshi M , Van EspenB, SharmaK. Metabolomics in diabetic kidney disease: unraveling the biochemistry of a silent killer. Am. J. Nephrol.44(2), 92–103 (2016).
   PubMed Web of Science ®Google Scholar
• Wishart DS , TzurD, KnoxCet al. HMDB: the human metabolome database. Nucleic Acids Res.35(Suppl. 1), D521–D526 (2007).
   PubMedGoogle Scholar
• Gao X , ChenW, LiRet al. Systematic variations associated with renal disease uncovered by parallel metabolomics of urine and serum. BMC Syst. Biol.6(1), S14 (2012).
   PubMedGoogle Scholar
• Gowda GN , ZhangS, GuH, AsiagoV, ShanaiahN, RafteryD. Metabolomics-based methods for early disease diagnostics. Expert Rev. Mol. Diagn.8(5), 617–633 (2008).
   PubMed Web of Science ®Google Scholar
• Bothwell JH , GriffinJL. An introduction to biological nuclear magnetic resonance spectroscopy. Biol. Rev.86(2), 493–510 (2011).
   PubMed Web of Science ®Google Scholar
• Alonso A , MarsalS, JuliàA. Analytical methods in untargeted metabolomics: state of the art in 2015. Front. Bioeng. Biotech.3, 23 (2015).
   PubMed Web of Science ®Google Scholar
• Lee J-E , LeeYH, KimS-Yet al. Systematic biomarker discovery and coordinative validation for different primary nephrotic syndromes using gas chromatography–mass spectrometry. J. Chrom. A1453, 105–115 (2016).
   PubMed Web of Science ®Google Scholar
• Hao X , LiuX, WangWet al. Distinct metabolic profile of primary focal segmental glomerulosclerosis revealed by NMR-based metabolomics. PLoS ONE8(11), e78531 (2013).
   PubMed Web of Science ®Google Scholar
• Sohrabi-Jahromi S , MarashiS-A, KalantariS. A kidney-specific genome-scale metabolic network model for analyzing focal segmental glomerulosclerosis. Mamm. Genome27(3–4), 158–167 (2016).
   PubMed Web of Science ®Google Scholar
• Mirfazeli ES , MarashiS-A, KalantariS. In silico prediction of specific pathways that regulate mesangial cell proliferation in IgA nephropathy. Med. Hypotheses97, 38–45 (2016).
   PubMed Web of Science ®Google Scholar
• Gadegbeku CA , GipsonDS, HolzmanLBet al. Design of the Nephrotic Syndrome Study Network (NEPTUNE) to evaluate primary glomerular nephropathy by a multidisciplinary approach. Kidney Int.83(4), 749–756 (2013).
   PubMed Web of Science ®Google Scholar